Efficacy and safety investigation of NNC0194-0499 co- administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial

Braude, Michael (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

Monash Health Local Reference: RES-23-0000-401X
SSA code: SSA/98160/MonH-2023-376458(v2)

Status	Active
Effective start/end date	25/07/23 → 24/07/28